209 related articles for article (PubMed ID: 30178793)
1. A comprehensively revised strategy that improves the specific activity and long-term stability of clinically relevant
Bhatt NB; Pandya DN; Rideout-Danner S; Gage HD; Marini FC; Wadas TJ
Dalton Trans; 2018 Oct; 47(37):13214-13221. PubMed ID: 30178793
[TBL] [Abstract][Full Text] [Related]
2.
Pandya DN; Bhatt NB; Almaguel F; Rideout-Danner S; Gage HD; Solingapuram Sai KK; Wadas TJ
J Nucl Med; 2019 May; 60(5):696-701. PubMed ID: 30442753
[No Abstract] [Full Text] [Related]
3. Site-specifically labeled
Kristensen LK; Christensen C; Jensen MM; Agnew BJ; Schjöth-Frydendahl C; Kjaer A; Nielsen CH
Theranostics; 2019; 9(15):4409-4420. PubMed ID: 31285769
[TBL] [Abstract][Full Text] [Related]
4. Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
Jauw YW; Menke-van der Houven van Oordt CW; Hoekstra OS; Hendrikse NH; Vugts DJ; Zijlstra JM; Huisman MC; van Dongen GA
Front Pharmacol; 2016; 7():131. PubMed ID: 27252651
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
[TBL] [Abstract][Full Text] [Related]
6. Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.
Jauw YWS; Heijtel DF; Zijlstra JM; Hoekstra OS; de Vet HCW; Vugts DJ; Verheul HM; Boellaard R; Zweegman S; van Dongen GAMS; der Houven van Oordt CWM; Lammertsma AA; Huisman MC
Mol Imaging Biol; 2018 Dec; 20(6):1025-1034. PubMed ID: 29713958
[TBL] [Abstract][Full Text] [Related]
7. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.
Perk LR; Vosjan MJ; Visser GW; Budde M; Jurek P; Kiefer GE; van Dongen GA
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):250-9. PubMed ID: 19763566
[TBL] [Abstract][Full Text] [Related]
8.
Jauw YWS; O'Donoghue JA; Zijlstra JM; Hoekstra OS; Menke-van der Houven van Oordt CW; Morschhauser F; Carrasquillo JA; Zweegman S; Pandit-Taskar N; Lammertsma AA; van Dongen GAMS; Boellaard R; Weber WA; Huisman MC
J Nucl Med; 2019 Dec; 60(12):1825-1832. PubMed ID: 31147401
[No Abstract] [Full Text] [Related]
9. Bifunctional octadentate pseudopeptides as Zirconium-89 chelators for immuno-PET applications.
Albanese V; Roccatello C; Pacifico S; Guerrini R; Preti D; Gentili S; Tegoni M; Remelli M; Bellotti D; Amico J; Gorgoni G; Cazzola E
EJNMMI Radiopharm Chem; 2024 May; 9(1):38. PubMed ID: 38705946
[TBL] [Abstract][Full Text] [Related]
10. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
[TBL] [Abstract][Full Text] [Related]
11. [
Zettlitz KA; Tsai WK; Knowles SM; Salazar FB; Kobayashi N; Reiter RE; Wu AM
Mol Imaging Biol; 2020 Apr; 22(2):367-376. PubMed ID: 31209779
[TBL] [Abstract][Full Text] [Related]
12. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
[TBL] [Abstract][Full Text] [Related]
13. Current Perspectives on
Yoon JK; Park BN; Ryu EK; An YS; Lee SJ
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560337
[No Abstract] [Full Text] [Related]
14. Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET.
Ruggiero A; Holland JP; Hudolin T; Shenker L; Koulova A; Bander NH; Lewis JS; Grimm J
J Nucl Med; 2011 Oct; 52(10):1608-15. PubMed ID: 21908391
[TBL] [Abstract][Full Text] [Related]
15. Immuno-positron emission tomography: shedding light on clinical antibody therapy.
van Dongen GA; Vosjan MJ
Cancer Biother Radiopharm; 2010 Aug; 25(4):375-85. PubMed ID: 20707716
[TBL] [Abstract][Full Text] [Related]
16. Interobserver reproducibility of tumor uptake quantification with
Jauw YWS; Bensch F; Brouwers AH; Hoekstra OS; Zijlstra JM; Pieplenbosch S; Schröder CP; Zweegman S; van Dongen GAMS; Menke-van der Houven van Oordt CW; de Vries EGE; de Vet HCW; Boellaard R; Huisman MC
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1840-1849. PubMed ID: 31209514
[TBL] [Abstract][Full Text] [Related]
17. Preclinical PET imaging with the novel human antibody
Kelly MP; Makonnen S; Hickey C; Arnold TC; Giurleo JT; Tavaré R; Danton M; Granados C; Chatterjee I; Dudgeon D; Retter MW; Ma D; Olson WC; Thurston G; Kirshner JR
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33483343
[TBL] [Abstract][Full Text] [Related]
18. Application of
Stergiou N; Wuensche TE; Schreurs M; Mes I; Verlaan M; Kooijman EJM; Windhorst AD; Helboe L; Vergo S; Christensen S; Asuni AA; Jensen A; Van Dongen GAMS; Bang-Andersen B; Vugts DJ; Beaino W
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1306-1317. PubMed ID: 36635462
[TBL] [Abstract][Full Text] [Related]
19. Imaging Very Late Antigen-4 on MOLT4 Leukemia Tumors with Cysteine Site-Specific
Kim M; Jung KH; Kim JL; Koo HJ; Jung HJ; Lee H; Lee KH
Mol Pharm; 2024 Mar; 21(3):1353-1363. PubMed ID: 38282332
[TBL] [Abstract][Full Text] [Related]
20. Folate Receptor α-Targeted
Heo GS; Detering L; Luehmann HP; Primeau T; Lee YS; Laforest R; Li S; Stec J; Lim KH; Lockhart AC; Liu Y
Mol Pharm; 2019 Sep; 16(9):3996-4006. PubMed ID: 31369274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]